Pelthos Therapeutics(PTHS)
$6.38-0.61 (-8.73%)
PTHS
Pelthos Therapeutics financials statements
$6.38
At close:-0.61 (-8.73%)
Want to see PTHS full AI Analyst Report?
Pelthos Therapeutics (PTHS) Ratios
77 Followers
Pelthos Therapeutics Ratios
PTHS's free cash flow for Q3 2026 was $-5.22M. For the 2026 fiscal year, PTHS's free cash flow was decreased by $-60.00K and operating cash flow was $-5.16M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.03 | 0.34 | 0.01 | 0.01 | 0.00 |
| Quick Ratio | 1.12 | 0.34 | 0.01 | 0.01 | 0.00 |
| Cash Ratio | 0.69 | 0.13 | 0.01 | 0.01 | 0.00 |
| Solvency Ratio | -0.45 | -1.95 | -1.13 | -0.65 | 0.00 |
| Operating Cash Flow Ratio | -0.87 | -1.42 | -0.15 | -0.42 | 0.00 |
| Short-Term Operating Cash Flow Coverage | -35.57 | -2.65 | -0.77 | -2.90 | 0.00 |
| Net Current Asset Value | $ -38.82M | $ -2.71M | $ -6.44M | $ -3.71M | $ 0.00 |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 1.60 | 13.16 | 9.81 | 0.00 |
| Debt-to-Equity Ratio | 0.90 | -0.81 | -0.20 | -0.15 | 0.00 |
| Debt-to-Capital Ratio | 0.47 | -4.14 | -0.25 | -0.17 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.35 | -0.50 | -0.01 | -0.01 | 0.00 |
| Debt Service Coverage Ratio | -10.43 | -2.41 | -3.84 | -3.40 | 0.00 |
| Interest Coverage Ratio | -10.77 | -9.63 | -13.23 | -16.51 | -3316.19 |
| Debt to Market Cap | 0.55 | 0.32 | 0.19 | 0.08 | 0.00 |
| Interest Debt Per Share | 20.12 | 5.06 | 3.10 | 1.18 | 0.00 |
| Net Debt to EBITDA | -0.37 | -0.23 | -0.17 | -0.21 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.24% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -283.98% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -270.37% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -193.09% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -301.91% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -257.93% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -257.93% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 85.43% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 156.36% | 105.07% | 107.56% | 106.06% | 70.96% |
| Return on Assets (ROA) | -33.22% | -581.05% | -7657.14% | -4464.16% | 0.00% |
| Return on Equity (ROE) | -111.41% | 293.12% | 114.53% | 66.33% | 0.00% |
| Return on Capital Employed (ROCE) | -31.06% | 278.97% | 106.48% | 62.54% | 0.00% |
| Return on Invested Capital (ROIC) | -26.38% | 1434.03% | 132.58% | 73.22% | 0.00% |
| Return on Tangible Assets | -65.39% | -581.05% | -7657.14% | -4464.16% | 0.00% |
| Earnings Yield | -74.31% | -114.73% | -108.45% | -36.13% | -8.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 3.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 1.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 994.92 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 192.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 918.79 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 116.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 1111.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -12.01 | -9.86 | -1.70 | -2.72 | 0.00 |
| Free Cash Flow Per Share | -12.07 | -9.86 | -1.70 | -2.72 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -228.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -228.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.65 | -2.65 | -0.77 | -2.90 | 0.00 |
| Operating Cash Flow to Sales Ratio | -1.35 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -38.92% | -83.54% | -14.41% | -23.03% | 0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.35 | -0.87 | -0.92 | -2.77 | -11.43 |
| Price-to-Sales (P/S) Ratio | 3.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.50 | -2.55 | -1.06 | -1.84 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.57 | -1.20 | -6.94 | -4.34 | 0.00 |
| Price-to-Operating Cash Flow Ratio | -2.58 | -1.20 | -6.94 | -4.34 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | -0.15 | -0.00 | -0.01 | 0.88 |
| Enterprise Value Multiple | -1.65 | -1.20 | -1.16 | -3.15 | 0.00 |
| Enterprise Value | 75.10M | 8.61M | 7.98M | 7.29M | 0 |
| EV to EBITDA | -1.65 | -1.20 | -1.16 | -3.15 | 0.00 |
| EV to Sales | 4.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.31 | -1.49 | -8.13 | -4.65 | 0.00 |
| EV to Operating Cash Flow | -3.32 | -1.49 | -8.13 | -4.65 | 0.00 |
| Tangible Book Value Per Share | -13.44 | -4.62 | -11.17 | -6.43 | 0.00 |
| Shareholders’ Equity Per Share | 20.68 | -4.62 | -11.17 | -6.43 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 8.93 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -23.04 | -13.54 | -12.80 | -4.26 | -1.03 |
| Tax Burden | 0.85 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.06 | 1.11 | 1.08 | 1.06 | 1.00 |
| Research & Development to Revenue | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 2.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.52 | 0.73 | 0.13 | 0.64 | 0.00 |
Currency in USD

